Stability and Outcomes of Non-displaced Lisfranc Injuries

April 28, 2023 updated by: Ostfold Hospital Trust

Stability and Outcomes of Non-displaced Lisfranc Injuries - A Prospective Multicenter Cohort Study

In this multicenter cohort study, the stability of non-displaced Lisfranc injuries as well as their outcomes will be evaluated.

Study Overview

Detailed Description

Injuries to the tarsometatarsal joints ("Lisfranc injuries") that are non-displaced on non-weightbearing radiographs and CT are common injuries. To refer these injuries to the right treatment, evaluating their stability is essential. For this purpose, both weightbearing radiographs and stress fluoroscopy have been proposed. However, there is no consensus concerning both the use and interpretation of weightbearing radiographs and no standardized technique and interpretation of stress fluoroscopy in non-displaced Lisfranc injuries.

In the current study, participants will be assigned to non-operative or operative treatment based on Lisfranc joint stability evaluation by weightbearing radiographs.

All Patients with negative weightbearing radiographs will be treated conservatively. In addition, their injured feet will be evaluated by manual stress fluoroscopy. Depending on the result of the stress fluoroscopy (positive/negative), the conservatively treated patients will be assigned to 2 cohorts, whose outcomes will be compared.

Patients with positive weightbearing radiographs will be treated operatively by minimally invasive stabilization of the midfoot (eg. isolated "homerun screw"). The operatively treated patients will be followed up as an independent cohort.

Study Type

Interventional

Enrollment (Actual)

131

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0588
        • Oslo university hospial
    • Østfold
      • Sarpsborg, Østfold, Norway, 1714
        • Østfold Hospital Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Acute Lisfranc injuries that are non-displaced (< 2mm) on non-weightbearing radiographs and CT
  • Patients between 18 and 70 years of age
  • Acute presentation at one of our departments, enabling evaluating the stability of the injuries within 4 weeks

Exclusion Criteria:

  • Fractures with an intraarticular step of > 2mm on the initial non weight-bearing radiographs and/or CT
  • Delayed presentation (weight-bearing radiographs taken > 4 weeks after injury)
  • Bilateral injuries
  • Concomitant major injuries of the foot, ankle or leg that affect the rehabilitation process
  • Multitraumized patients
  • Previous injury or surgery of the mid foot
  • Charcot foot
  • Noncompliant patients
  • Insufficient Norwegian or English language skills
  • Patients not available for follow-up
  • Inability to conduct the rehabilitation protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Negative WB radiographs and stress fluoroscopy

Cohort 1

Negative weight bearing radiographs:

Interval between medial cuneiform and base of the second metatarsal (C1-M2) are less than 2mm increased compared to the uninjured side.

Negative stress fluoroscopy: the midfoot is tested stable

Patients with negative weightbearing radiographs will be treated conservatively
Active Comparator: Negative WB radiographs / positive stress fluoroscopy

Cohort 2

Negative weight bearing radiographs:

Interval between medial cuneiform and base of the second metatarsal (C1-M2) are less than 2mm increased compared to the uninjured side.

Positive stress fluoroscopy: manual testing reveals midfoot instability

Patients with negative weightbearing radiographs will be treated conservatively
Other: Surgical cohort (Cohort 3)
Patients with positive weightbearing radiographs will be operated on with minimally invasive technique and followed up as an independent cohort.
Patients with positive weightbearing radiographs will be operated by minimally invasive stabilization (eg, isolated homerun screw)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manchester-Oxford Foot Questionnaire (MOxFQ)
Time Frame: 5 years
Foot-Ankle specific PROM (0-100 with 0 representing the best possible outcome)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Midfoot score
Time Frame: 5 years
Widely used foot/ankle score (0-100 with 100 representing the best possible outcome)
5 years
Self-reported foot and ankle score (SEFAS)
Time Frame: 5 years
Foot-Ankle specific PROM (0-48 with 48 representing the best possible outcome)
5 years
Visual Analogue Scale (VAS) for pain
Time Frame: 5 years
Scores pain at rest and on activity (0-10 with 0 representing no pain)
5 years
Short-Form (SF) 36
Time Frame: 5 years
Patient reported score measuring quality of life and health status
5 years
Posttraumatic osteoarthritis
Time Frame: 5 years
The presence of osteoarthritis of the tarsometatarsal joints is graded based on the Brodén radiographs taken at 1 year, 2 year and 5 year follow-up using the Kellgren & Lawrence classification system.
5 years
Incidence of complications
Time Frame: 5 years
Yes/no for deep or superficial infection, nerve or tendon injury, deep venous thrombosis, hardware complaints and secondary surgery. Regards the patients that have undergone surgical treatment.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Marius Molund, MD, Ostfold Hospital Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2020

Primary Completion (Anticipated)

December 31, 2028

Study Completion (Anticipated)

December 31, 2029

Study Registration Dates

First Submitted

June 10, 2020

First Submitted That Met QC Criteria

June 10, 2020

First Posted (Actual)

June 12, 2020

Study Record Updates

Last Update Posted (Actual)

May 1, 2023

Last Update Submitted That Met QC Criteria

April 28, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20/00913

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lisfranc Injury

Clinical Trials on Conservative treatment

Subscribe